A drug report jointly released by Major League Baseball and the players' union Friday show that Adderall use is on the rise, among other findings.
The report was submitted by Dr. Jeffrey M. Anderson, MLB's independent program administrator of the Joint Drug Prevention and Treatment Program. It covers the 2012 offseason through the 2013 season and only applies to players on major-league 40-man rosters.
The main findings from the report include:
--The total number of drug tests that were conducted for the presence of performance-enhancing substances and/or stimulants was 5,391. The number of urine samples collected and analyzed for the presence of performance-enhancing substances and/or stimulants was 4,022. The number of blood samples that were collected and analyzed for the presence of human growth hormone was 1,369.
--Eight tests were reported by the testing laboratory for having an adverse analytical finding that resulted in discipline. All were for stimulants. The substances reported were Adderall (seven) and Methylhexaneamine (one).
The Los Angeles Times reported that one in 10 players are treated for Attention Deficit Disorder (ADD) with Adderall, which is about double the rate of the general population. The number of Adderall exemptions in MLB has increased significantly since 2006 -- 28 in 2006 to 103 in 2007 -- when amphetamines were banned.
Most players using Adderall are doing so under the direction of a doctor and with approval from MLB.
--Thirteen non-analytical positives resulted in discipline. Those represent the players suspended for their link to former South Florida anti-aging clinic Biogenesis.
--Therapeutic use exemptions were granted to 122 players. The diagnoses were 119 for ADD and three for hypogonadism (a body's sex glands produce little or no hormones).